Considering this finding, we sought to determine whether bortezomib can decrease Smurf2 expression in NSCLC cells and to further examine the effects of pharmacological inhibition of Smurf2 signaling with bortezomib in combination with cisplatin and radiation. Here, SMURF2 is linked to non-small cell lung carcinoma.